FITC anti-mouse CD45.2 Antibody

Pricing & Availability
Clone
104 (See other available formats)
Regulatory Status
RUO
Other Names
Ly-5.2, LCA
Isotype
Mouse (SJL) IgG2a, κ
Ave. Rating
Submit a Review
Product Citations
publications
104_FITC_090507
C57BL/6 mouse splenocytes stained with 104 FITC
  • 104_FITC_090507
    C57BL/6 mouse splenocytes stained with 104 FITC
Compare all formats See FITC spectral data
Cat # Size Price Quantity Check Availability Save
109805 50 µg 54 CHF
Check Availability


Need larger quantities of this item?
Request Bulk Quote
109806 500 µg 116 CHF
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD45.2 is an alloantigen of CD45, expressed by Ly5.2 bearing mouse strains (e.g., A, AKR, BALB/c, CBA/Ca, CBA/J, C3H/He, C57BL, C57BR, C57L, C58, DBA/1, DBA/2, NZB, SWR, 129). CD45, a member of the protein tyrosine phosphatase (PTP) family, is a 180-240 kD glycoprotein expressed on all hematopoietic cells except mature erythrocytes and platelets. There are multiple isoforms in the mouse that play key roles in TCR and BCR signal transduction. These isoforms are very specific to the activation and maturation states of the cell as well as specific cell type. The primary ligands for CD45 are galectin-1, CD2, CD3, CD4, TCR, CD22, and Thy-1.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Mouse
Immunogen
B10.S mouse thymocytes and splenocytes
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with FITC under optimal conditions.
Concentration
0.5 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested

Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Application Notes

The 104 antibody does not react with mouse cells expressing the CD45.1 alloantigen. Additional reported applications (for the relevant formats) include: immunoprecipitation4, in vivo and in vitro blocking of B cell responses1,2, and immunohistochemical staining of acetone-fixed frozen sections3

Application References

(PubMed link indicates BioLegend citation)
  1. Yakura H, et al. 1983. J. Exp. Med. 157:1077. (Block)
  2. Yakura H, et al. 1986. J. Immunol. 136:2729. (Block)
  3. Suzuki K, et al. 2000. Immunity 13:691. (IHC)
  4. Shen FW, et al. 1986. Immunogenetics 24:146. (IP)
  5. Baldwin TA and Hogquist KA. 2007. J. Immunol. 179:837.
  6. Pascal V, et al. 2007. J. Immunol. 179:1751.
  7. Burman AC, et al. 2007. Blood 110:1064.
  8. Kincaid EZ, et al. 2007. J. Immunol. 179:3187.
  9. Phan TG, et al. 2007. Nature Immunol. 8:992.
  10. Nakano-Yokomizo T, et al. 2011. J. Exp Med. 208:1661. PubMed
  11. Wen T, et al. 2013. PNAS. 110:6067. PubMed
  12. Kohlmeier JE, et al. 2008. Immunity. 29:101. (FC) PubMed
Product Citations
  1. Zheng J, et al. 2022. Front Pharmacol. 13:866228. PubMed
  2. Miranda K, et al. 2022. iScience. 25:104994. PubMed
  3. Koyama M, et al. 2015. J Exp Med. 212: 1303 - 1321. PubMed
  4. Otano I, et al. 2021. Nat Commun. 12:7296. PubMed
  5. Michalova J, et al. 2011. Biol Blood Marrow Transplant. 17:1273. PubMed
  6. Stewart I et al. 2018. Immunity. 49(3):477-489 . PubMed
  7. Kim CJ, et al. 2018. Immunity. 49:1034. PubMed
  8. Piepke M, et al. 2021. J Neuroinflammation. 18:265. PubMed
  9. MacDonald K, et al. 2014. J Immunol. 192:3180. PubMed
  10. Tan X, et al. 2016. PLoS One. 11: 0160985. PubMed
  11. Burman A, et al. 2007. Blood. 110:1064. PubMed
  12. Bhattacharjee S, et al. 2019. Cell Rep. 28:231. PubMed
  13. Sultan H, et al. 2018. Cancer Immunol Res. 6:617. PubMed
  14. Yuzhu Hou et al. 2018. Immunity. 49(3):490-503 . PubMed
  15. Yang X, et al. 2020. Blood Sci. 2:89. PubMed
  16. Liang Y, et al. 2020. J Immunol. 204:2984. PubMed
  17. Wei Q, et al. 2021. Nat Commun. 12:2522. PubMed
  18. Acharya N, et al. 2020. Immunity. 53(3):658-671.e6. PubMed
  19. Swidergall M, et al. 2019. Cell Rep. 28:423. PubMed
  20. Liu Y, et al. 2021. Haematologica. Online ahead of print. PubMed
  21. Atkin-Smith G, et al. 2017. Sci Rep. 7:39846. PubMed
  22. Okuniewska M, et al. 2021. Cell Reports. 36(2):109368. PubMed
  23. Tran L, et al. 2017. Cancer Immunol Res. 5:1141. PubMed
  24. Khan IM, et al. 2021. Immunohorizons. 5:703. PubMed
  25. Mitchell JE, et al. 2021. Cell Reports. 35(2):108966. PubMed
  26. Emgård J, et al. 2018. Immunity. 143:419. PubMed
  27. Uchil PD et al. 2018. Cell host & microbe. 25(1):87-100 . PubMed
  28. Wang H, et al. 2019. Nat Commun. 10:1898. PubMed
  29. Schulz A, et al. 2019. Cell Rep. 29:1074. PubMed
  30. Guiducci E, et al. 2018. Front Immunol. 1.467361111. PubMed
  31. Zhang J, et al. 2022. iScience. 25:104963. PubMed
  32. Kaplan BLF et al. 2018. Current protocols in toxicology. 75:11:00 25. PubMed
  33. Kleppe M et al. 2018. Cancer cell. 33(1):29-43 . PubMed
  34. Trompette A, et al. 2022. Mucosal Immunol. :. PubMed
  35. Zhang B, et al. 2021. Nat Biomed Eng. 5:1288. PubMed
  36. Friedman DJ, et al. 2021. Cancer Immunol Res. 9:952. PubMed
  37. Glaros V, et al. 2021. Immunity. 54:2005. PubMed
  38. Li J, et al. 2020. Elife. 9:00. PubMed
  39. Li Y, et al. 2020. Cell Stem Cell. 27(5):732-747.e7. PubMed
  40. Derecka M, et al. 2020. Nat Immunol. 261:21. PubMed
  41. Wan X, et al. 2018. Nature. 560:107. PubMed
  42. Malik A et al. 2018. Immunity. 49(3):515-530 . PubMed
  43. Bergin SM, et al. 2021. Brain Behav Immun. 95:477. PubMed
  44. Chen X, et al. 2021. Cell Rep. 37:109991. PubMed
  45. Faulhaber LD, et al. 2022. Neurophotonics. 9:031917. PubMed
  46. Platteel A, et al. 2017. Vaccine.. 10.1016/j.vaccine.2017.10.044. PubMed
  47. Abbott RK, et al. 2018. Immunity. 48:133. PubMed
  48. Bijalwan M, et al. 2019. Sci Rep. 9:3444. PubMed
  49. Dey S, et al. 2020. J Immunother Cancer. 8:. PubMed
  50. Kruta M, et al. 2021. Cell Stem Cell. :. PubMed
  51. Stifter SA, et al. 2019. Cell Rep. 29:3539. PubMed
  52. Landon J Edgar et al. 2018. Cell chemical biology. 26(1):131-136 . PubMed
  53. Ma W, et al. 2017. Cell Death & Disease. 10.1038/cddis.2017.47. PubMed
  54. Uslu M, et al. 2020. J Cell Physiol. 235:9644. PubMed
  55. Bates PD, et al. 2021. Front Immunol. 12:668307. PubMed
  56. Huang D, et al. 2020. Nat Commun. 4.520833333. PubMed
  57. Leon-Rico D, et al. 2015. Lab Anim. 49:132. PubMed
  58. Morelli AE, et al. 2020. Cell Rep. 30:3448. PubMed
  59. Xu P, et al. 2020. Cancer Immunol Res. 8:1193. PubMed
  60. Zhang W, et al. 2022. Nat Methods. 19:759. PubMed
  61. Burgess M, et al. 2014. Blood. 124:3947. PubMed
  62. Kesavardhana S, et al. 2020. J Biol Chem. 295:8325. PubMed
  63. de Laval B, et al. 2020. Cell Stem Cell. 26(5):657-674. PubMed
  64. Williams JB, et al. 2020. Nat Commun. 0.876388889. PubMed
  65. Nelson CE et al. 2019. Cell Rep. 28(12):3092-3104 . PubMed
  66. Zeis P, et al. 2020. Immunity. 53:775. PubMed
  67. Chen R, et al. 2021. Cell Reports. 34(7):108751. PubMed
  68. Wu B, et al. 2021. Immunity. 54(2):308-323.e6. PubMed
  69. Swanson P, et al. 2016. PLoS Pathog. 12:e1006022. PubMed
  70. Kang YH, et al. 2019. Nat Commun. 10:912. PubMed
  71. Alexander Mildner et al. 2017. Immunity. 46(5):849-862 . PubMed
  72. Li E, et al. 2021. Front Immunol. 12:667177. PubMed
  73. Kissiov DU, et al. 2022. Elife. 11:. PubMed
  74. Zhang C, et al. 2021. J Immunother Cancer. 9:. PubMed
  75. Jaako P, et al. 2016. Leukemia. 10.1038/leu.2016.159. PubMed
  76. Zhu YP et al. 2018. Cell reports. 24(9):2329-2341 . PubMed
  77. Düking T, et al. 2022. Sci Adv. 8:eabo7639. PubMed
  78. Ma L, et al. 2022. Sci Adv. 8:eabm3470. PubMed
  79. Koide S, et al. 2022. iScience. 25:103603. PubMed
  80. Peter Morawski, Chen-Feng Qi, Silvia Boll 2017. Sci Rep. 7:40838. PubMed
  81. Sade–Feldman M, et al. 2018. Cell. 175:998. PubMed
  82. Field CS, et al. 2020. Cell Metab. 31:422. PubMed
  83. Magee JA, et al. 2021. Stem Cell Reports. 16:20. PubMed
  84. Okuyama Y, et al. 2020. FASEB J. 540:34. PubMed
  85. Zhang J, et al. 2019. Exp Hematol. 78:21:00. PubMed
  86. Hidalgo San Jose L, et al. 2020. Cell Rep. 30:69. PubMed
  87. Gundra UM, et al. 2017. Nat Immunol. 1.195833333. PubMed
  88. Halvarsson C, et al. 2019. Antioxid Redox Signal. 31:211. PubMed
  89. Heckler M, et al. 2021. Cancer Discov. Online ahead of prin. PubMed
  90. Kohn M, et al. 2021. Front Immunol. 626627:12. PubMed
  91. Ubags ND, et al. 2021. J Allergy Clin Immunol. 1049:147. PubMed
  92. Bosma M, et al. 2016. Nat Commun. 7: 11314. PubMed
  93. Andresen L, et al. 2016. PLoS One. 11: 0148428. PubMed
  94. Radulovic V, et al. 2020. Cell Reports. 27(10):2826-2836.e5.. PubMed
  95. Hung LY, et al. 2019. J Immunol. 203:511. PubMed
  96. Koyama M et al. 2019. Immunity. 51(5):885-898 . PubMed
  97. Stienstra R, et al. 2014. Diabetes. 63:4143. PubMed
  98. Corrado M, et al. 2020. Cell Metab. 32:981. PubMed
  99. Goldberg EL, et al. 2021. Cell Metabolism. :. PubMed
  100. Bing Wu et al. 2018. Immunity. 49(5):886-898 . PubMed
  101. Hsieh WC, et al. 2018. Nat Commun. 9:463. PubMed
  102. Sethuraman SN, et al. 2020. Theranostics. 10:3397. PubMed
RRID
AB_313442 (BioLegend Cat. No. 109805)
AB_313443 (BioLegend Cat. No. 109806)

Antigen Details

Structure
Protein tyrosine phosphatase (PTP) family, 180-240 kD
Distribution

All hematopoietic cells except mature erythrocytes and platelets of the CD45.2 strain of mice

Function
Phosphatase, T and B cell activation
Ligand/Receptor
Galectin-1, CD2, CD3, CD4
Biology Area
Cell Biology, Immunology, Inhibitory Molecules, Innate Immunity, Neuroscience, Neuroscience Cell Markers
Molecular Family
CD Molecules
Antigen References

1. Suzuki K, et al. 2000. Immunity 13:691.

Gene ID
19264 View all products for this Gene ID
UniProt
View information about CD45.2 on UniProt.org

Related FAQs

There are no FAQs for this product.
Go To Top Version: 1    Revision Date: 11.30.2012

For research use only. Not for diagnostic use. Not for resale. BioLegend will not be held responsible for patent infringement or other violations that may occur with the use of our products.

 

*These products may be covered by one or more Limited Use Label Licenses (see the BioLegend Catalog or our website, www.biolegend.com/ordering#license). BioLegend products may not be transferred to third parties, resold, modified for resale, or used to manufacture commercial products, reverse engineer functionally similar materials, or to provide a service to third parties without written approval of BioLegend. By use of these products you accept the terms and conditions of all applicable Limited Use Label Licenses. Unless otherwise indicated, these products are for research use only and are not intended for human or animal diagnostic, therapeutic or commercial use.

 

BioLegend Inc., 8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

  • Biotin anti-mouse CD45.2

  • FITC anti-mouse CD45.2

  • PE anti-mouse CD45.2

  • Purified anti-mouse CD45.2

  • APC anti-mouse CD45.2

  • Alexa Fluor® 488 anti-mouse CD45.2

  • Alexa Fluor® 647 anti-mouse CD45.2

  • Pacific Blue™ anti-mouse CD45.2

  • Alexa Fluor® 700 anti-mouse CD45.2

  • APC/Cyanine7 anti-mouse CD45.2

  • PerCP anti-mouse CD45.2

  • PerCP/Cyanine5.5 anti-mouse CD45.2

  • PE/Cyanine7 anti-mouse CD45.2

  • Brilliant Violet 421™ anti-mouse CD45.2

  • Brilliant Violet 570™ anti-mouse CD45.2

  • Brilliant Violet 650™ anti-mouse CD45.2

  • Brilliant Violet 510™ anti-mouse CD45.2

  • Brilliant Violet 785™ anti-mouse CD45.2

  • Brilliant Violet 605™ anti-mouse CD45.2

  • Purified anti-mouse CD45.2 (Maxpar® Ready)

  • PE/Dazzle™ 594 anti-mouse CD45.2

  • Brilliant Violet 711™ anti-mouse CD45.2

  • Alexa Fluor® 594 anti-mouse CD45.2

  • APC/Fire™ 750 anti-mouse CD45.2

  • TotalSeq™-A0157 anti-mouse CD45.2

  • TotalSeq™-B0157 anti-mouse CD45.2

  • TotalSeq™-C0157 anti-mouse CD45.2

  • Brilliant Violet 750™ anti-mouse CD45.2

  • Spark Blue™ 550 anti-mouse CD45.2

  • Spark NIR™ 685 anti-mouse CD45.2

ProductsHere

Login / Register
Remember me
Forgot your password? Reset password?
Create an Account